| Name: | BRECKENRIDGE PHARMACEUTICAL, INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Inactive |
| Date of registration: | 06 Dec 2018 (6 years ago) (Companies founded in December 2018) |
| Date of dissolution: | 24 May 2024 |
| Branch of: | BRECKENRIDGE PHARMACEUTICAL, INC. (Company Number F24000003057) (Florida) |
| Entity Number: | 5454288 |
| ZIP code: | 06037 (Companies in New York, 06037) |
| County: | New York |
| Place of Formation: | Florida |
| Address: | ATTN: PRESIDENT & GEN. COUNSEL, 15 MASSIRIO DRIVE, SUITE 201, BERLIN, CT, United States, 06037 |
| Principal Address: | 15 MASSIRIO DRIVE, SUITE 201, BERLIN, CT, United States, 06037 |
| Name | Role | Address |
|---|---|---|
| THE CORPORATION | DOS Process Agent | ATTN: PRESIDENT & GEN. COUNSEL, 15 MASSIRIO DRIVE, SUITE 201, BERLIN, CT, United States, 06037 |
| Name | Role | Address |
|---|---|---|
| BRIAN GUY | Chief Executive Officer | 15 MASSIRIO DRIVE, SUITE 201, BERLIN, CT, United States, 06037 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2024-10-21 | 2024-10-21 | Address | 15 MASSIRIO DRIVE, SUITE 201, BERLIN, CT, 06037, USA (Type of address: Chief Executive Officer) |
| 2020-12-01 | 2024-10-21 | Address | 15 MASSIRIO DRIVE, SUITE 201, BERLIN, CT, 06037, USA (Type of address: Chief Executive Officer) |
| 2018-12-06 | 2024-10-21 | Address | ATTN: PRESIDENT & GEN. COUNSEL, 15 MASSIRIO DRIVE, SUITE 201, BERLIN, CT, 06037, USA (Type of address: Service of Process) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 241021002517 | 2024-05-24 | CERTIFICATE OF TERMINATION | 2024-05-24 |
| 221215003652 | 2022-12-15 | BIENNIAL STATEMENT | 2022-12-01 |
| 201201061163 | 2020-12-01 | BIENNIAL STATEMENT | 2020-12-01 |
| 181206000316 | 2018-12-06 | APPLICATION OF AUTHORITY | 2018-12-06 |
Date of last update: 22 Nov 2024
Sources: New York Secretary of State
